✦ LIBER ✦

Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia

✍ Scribed by C. Giardini; M. Galimbbrti; G. Lucarelli; P. Polchi; E. Angelucci; D. Baronciani; D. Gaziev; B. Erer; G. La Nasa; I. Barbanti; P. Muretto

Book ID: 114714487
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 586 KB
Volume: 89
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1995.tb08426.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fate of iron stores in thalassaemia afte

Fate of iron stores in thalassaemia after bone-marrow transplantation

✍ G Lucarelli; E Angelucci; C Giardini; D Baronciani; M Galimberti; P Polchi; F Al 📂 Article 📅 1993 🏛 The Lancet 🌐 English ⚖ 528 KB

Early iron reduction programme for thala

Early iron reduction programme for thalassaemia patients after bone marrow transplantation

✍ Li, C K; Lai, D H; Shing, M M K; Chik, K W; Lee, V; Yuen, P M P 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 45 KB

Resolution of psoriasis after allogeneic

Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy

✍ Adkins, D R; Abidi, M H; Brown, R A; Khoury, H; Goodnough, L T; Vij, R; Westerve 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Aetiology of severe aplastic anaemia and

Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy

✍ A. Bacigalupo for the Working Party on Severe Aplastic Anaemia of the European B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Prediction of therapy-related acute myel

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th

Impact of cyclosporine and methylprednis

Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation

✍ Michallet, M; Perrin, M-C; Belhabri, A; Molina, L; Nicolini, F; Tigaud, J D; Sot 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 64 KB